Phase I study of telatinib (BAY 57-9352): analysis of safety, pharmacokinetics, tumor efficacy, and biomarkers in patients with colorectal cancer (Q35207190)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase I study of telatinib (BAY 57-9352): analysis of safety, pharmacokinetics, tumor efficacy, and biomarkers in patients with colorectal cancer |
scientific article |
Statements
1 reference
Phase I study of telatinib (BAY 57-9352): analysis of safety, pharmacokinetics, tumor efficacy, and biomarkers in patients with colorectal cancer (English)
1 reference
Klaus Mross
1 reference
Annette Frost
1 reference
Max E Scheulen
1 reference
Jürgen Krauss
1 reference
Dirk Strumberg
1 reference
Beate Schultheiss
1 reference
Ulrike Fasol
1 reference
Martin Büchert
1 reference
Jörn Krätzschmer
1 reference
Heinz Delesen
1 reference
Prabhu Rajagopalan
1 reference
Olaf Christensen
1 reference
29 July 2011
1 reference
1 reference
3
1 reference
16
1 reference
Identifiers
1 reference
1 reference
1 reference